Omkar Pharmachem Q2 FY27 Net Profit Rs. 0.39 lakhs, Income Rs. 9.00 lakhs
RESULTS
▼ Concern Flagged
HIGH RISK
📅 Filed on BSE: 14 Nov 2026, 05:31 PM IST · BSE ID: 47c8fb5c-949e-47e1-b2ca-f3f348d85de7
View Original BSE Filing (PDF)
💡
In Simple Terms
Omkar Pharmachem reported a net profit of Rs. 0.39 lakhs for the July-September 2026 quarter, with income mainly from other operations.
🤖 AI Summary
- Omkar Pharmachem Ltd reported a net profit of Rs. 0.39 lakhs for the quarter ended September 30, 2026 (Q2 FY27).
- Total income from operations for Q2 FY27 was Rs. 9.00 lakhs, composed entirely of other operating income.
- For the half year ended September 30, 2026 (H1 FY27), the company recorded a net loss of Rs. 0.62 lakhs.
- Basic and diluted Earnings Per Share for Q2 FY27 stood at Rs. 0.0039.
- The board approved these unaudited financial results at its meeting held on November 14, 2026.
🔢 Key Numbers - exact figures from BSE filing, not rounded
Net Sales/ Income from Operations (Q2 FY27)
0.00 Rs. in lakhs
Other Operating Income (Q2 FY27)
9.00 Rs. in lakhs
Net Total Income (Q2 FY27)
9.00 Rs. in lakhs
Profit(Loss) for the period (Q2 FY27)
0.39 Rs. in lakhs
Profit(Loss) for the period (H1 FY27)
(0.62) Rs. in lakhs
Cash and cash equivalents (as at 30-09-2026)
16.47 Rs. in lakhs
🏢 How This Affects the Company
Net sales/income from operations remained at Rs. 0.00 lakhs for Q2 FY27 and H1 FY27, similar to prior periods, indicating no core operational revenue generation.
The company reported a profit of Rs. 0.39 lakhs in Q2 FY27, but a half-year net loss of Rs. 0.62 lakhs, impacting overall profitability for the period. Cash and cash equivalents decreased to Rs. 16.47 lakhs as of September 30, 2026, from Rs. 21.73 lakhs on March 31, 2026.
The sustained absence of Net Sales/Income from Operations (Rs. 0.00 lakhs) suggests that the primary business activities are not generating revenue, with income derived from other operating sources.
The continued reliance on 'Other Operating Income' and lack of 'Net Sales/Income from Operations' introduces a risk regarding the sustainability and nature of its core business model.
👥 What This Means For Shareholders
✅
Action Required
No action is required from shareholders based on this financial results filing.
👤
Who Is Affected
All shareholders are affected by the company's financial performance, particularly the reported net profit of Rs. 0.39 lakhs for Q2 FY27 and the half-year net loss of Rs. 0.62 lakhs.
🔍
Management Signal
The financial results indicate management's continued operation of the company with income primarily from other operating sources, rather than direct sales.
For information only. Not investment advice. ForgeUp is not SEBI-registered.
👁 Watch List - track these upcoming events
Q3 FY27 financial results — check for changes in net sales and operating income trends.
Annual financial statements for FY27 — assess full year performance and balance sheet changes.
Board meeting outcomes — monitor any strategic decisions or business updates.
HIGH RISK
The company continues to report Rs. 0.00 lakhs in Net Sales/Income from Operations, indicating a lack of core business revenue.
💡 Investor Takeaway
Omkar Pharmachem reported a net profit of Rs. 0.39 lakhs for Q2 FY27, a decline from Rs. 5.07 lakhs in Q2 FY26. Total income from operations for Q2 FY27 was Rs. 9.00 lakhs, down from Rs. 13.50 lakhs in Q2 FY26. Notably, net sales/income from operations was Rs. 0.00 lakhs for the quarter and half year.
⚖️ Strengths & Concerns
⚠️ Concerns
- Net sales/income from operations remained at Rs. 0.00 lakhs for Q2 FY27, indicating no revenue from core business activities.
- Cash flow from operating activities was negative Rs. 5.26 lakhs for H1 FY27, decreasing cash and cash equivalents.
📅 Company Track Record
Omkar Pharmachem Ltd has consistently reported Rs. 0.00 lakhs for 'Net Sales/Income from Operations' in recent periods, including Q1 FY27, Q2 FY27, and H1 FY27. Prior filings confirm board meetings for approving unaudited financial results, highlighting a regular reporting schedule.
Based on publicly available historical data. For context only.
❓ Frequently Asked Questions
What was Omkar Pharmachem's net profit in Q2 FY27?
Omkar Pharmachem Ltd reported a net profit of Rs. 0.39 lakhs for the quarter ended September 30, 2026 (Q2 FY27).
What was Omkar Pharmachem's total income from operations in Q2 FY27?
The total income from operations for Omkar Pharmachem Ltd in Q2 FY27 was Rs. 9.00 lakhs, derived entirely from other operating income.
Did Omkar Pharmachem have any net sales in Q2 FY27?
No, Omkar Pharmachem Ltd reported Rs. 0.00 lakhs for 'Net Sales/Income from Operations' for the quarter ended September 30, 2026 (Q2 FY27).
What was Omkar Pharmachem's net profit/loss for the half year ended September 2026?
For the half year ended September 30, 2026 (H1 FY27), Omkar Pharmachem Ltd recorded a net loss of Rs. 0.62 lakhs.
Questions based on this BSE filing only. For information purposes.